Mrinal K Ghosh Selected Research

Ubiquitin

12/2023	E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities.
1/2022	Ubiquitination and deubiquitination in the regulation of epithelial-mesenchymal transition in cancer: Shifting gears at the molecular level.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mrinal K Ghosh Research Topics

Disease

23	Neoplasms (Cancer) 01/2024 - 06/2002
5	Glioma (Gliomas) 01/2024 - 11/2013
4	Breast Neoplasms (Breast Cancer) 07/2023 - 01/2013
4	Carcinogenesis 01/2023 - 01/2018
3	Colonic Neoplasms (Colon Cancer) 12/2023 - 07/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2022
2	COVID-19 07/2023 - 01/2023
2	Carcinoma (Carcinomatosis) 01/2023 - 07/2019
2	Glioblastoma (Glioblastoma Multiforme) 09/2017 - 11/2005
2	Melanoma (Melanoma, Malignant) 07/2014 - 06/2002
1	Lung Neoplasms (Lung Cancer) 12/2023
1	Triple Negative Breast Neoplasms 07/2023
1	Cytokine Release Syndrome 04/2023
1	Hypoxia (Hypoxemia) 04/2023
1	Stroke (Strokes) 01/2019
1	Thrombophilia 01/2019
1	Retinoblastoma (Glioblastoma, Retinal) 07/2014
1	Pathologic Processes 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 05/2012
1	Infections 01/2002

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2002
7	CateninsIBA 12/2023 - 05/2012
4	DEAD-box RNA HelicasesIBA 07/2023 - 07/2019
3	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 11/2005
3	RNA (Ribonucleic Acid)IBA 07/2023 - 07/2019
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023 - 01/2014
3	ErbB Receptors (EGF Receptor)IBA 09/2017 - 05/2012
2	Alkylating AgentsIBA 01/2024 - 12/2023
2	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 12/2023
2	Ligases (Synthetase)IBA 12/2023 - 11/2022
2	UbiquitinIBA 12/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 12/2023 - 10/2019
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 07/2019
2	RNA Helicases (RNA Helicase)IBA 01/2023 - 01/2023
2	Peptides (Polypeptides)IBA 09/2017 - 07/2014
2	3,3'-diindolylmethane (diindolylmethane)IBA 09/2017 - 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	atezolizumabIBA 07/2023
1	pembrolizumabIBA 07/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2023
1	VaccinesIBA 01/2023
1	Deubiquitinating EnzymesIBA 01/2023
1	CaspasesIBA 11/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	Tamoxifen FDA LinkGeneric 10/2019
1	SurvivinIBA 10/2019
1	fibrin fragment D (D-dimer)IBA 01/2019
1	somatostatin receptor 2IBA 09/2017
1	Essential DrugsIBA 09/2017
1	PeptoidsIBA 01/2017
1	Prolactin Receptors (Prolactin Receptor)IBA 09/2015
1	Protein Isoforms (Isoforms)IBA 09/2015
1	ubiquitin isopeptidaseIBA 08/2015
1	CalciumIBA 07/2014
1	Cell-Penetrating PeptidesIBA 07/2014
1	diphenyl (biphenyl)IBA 01/2013
1	2,2'-diphenyl-3,3'-diindolylmethaneIBA 01/2013
1	anthraceneIBA 01/2013
1	indoleIBA 01/2013
1	Glycogen Synthase Kinase 3IBA 05/2012
1	EpitopesIBA 06/2002

Therapy/Procedure

9	Therapeutics 01/2024 - 01/2013
2	Immunotherapy 07/2023 - 06/2002
1	Drug Therapy (Chemotherapy) 01/2024